These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21301704)

  • 1. No time to lose--high throughput screening to assess nanomaterial safety.
    Damoiseaux R; George S; Li M; Pokhrel S; Ji Z; France B; Xia T; Suarez E; Rallo R; Mädler L; Cohen Y; Hoek EM; Nel A
    Nanoscale; 2011 Apr; 3(4):1345-60. PubMed ID: 21301704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
    Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H
    Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.
    Liu Q; Wang X; Xia T
    Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment.
    Nel AE; Nasser E; Godwin H; Avery D; Bahadori T; Bergeson L; Beryt E; Bonner JC; Boverhof D; Carter J; Castranova V; Deshazo JR; Hussain SM; Kane AB; Klaessig F; Kuempel E; Lafranconi M; Landsiedel R; Malloy T; Miller MB; Morris J; Moss K; Oberdorster G; Pinkerton K; Pleus RC; Shatkin JA; Thomas R; Tolaymat T; Wang A; Wong J
    ACS Nano; 2013 Aug; 7(8):6422-33. PubMed ID: 23924032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for novel approaches in ecotoxicity of engineered nanomaterials.
    Kumar A; Dhawan A; Shanker R
    J Biomed Nanotechnol; 2011 Feb; 7(1):79-80. PubMed ID: 21485813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput toxicity screening and intracellular detection of nanomaterials.
    Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assessments of nanomaterial toxicity.
    Jones CF; Grainger DW
    Adv Drug Deliv Rev; 2009 Jun; 61(6):438-56. PubMed ID: 19383522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate.
    Zhu M; Nie G; Meng H; Xia T; Nel A; Zhao Y
    Acc Chem Res; 2013 Mar; 46(3):622-31. PubMed ID: 22891796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced tools for the safety assessment of nanomaterials.
    Fadeel B; Farcal L; Hardy B; Vázquez-Campos S; Hristozov D; Marcomini A; Lynch I; Valsami-Jones E; Alenius H; Savolainen K
    Nat Nanotechnol; 2018 Jul; 13(7):537-543. PubMed ID: 29980781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials.
    George S; Xia T; Rallo R; Zhao Y; Ji Z; Lin S; Wang X; Zhang H; France B; Schoenfeld D; Damoiseaux R; Liu R; Lin S; Bradley KA; Cohen Y; Nel AE
    ACS Nano; 2011 Mar; 5(3):1805-17. PubMed ID: 21323332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?
    Hoet P; Legiest B; Geys J; Nemery B
    Drug Saf; 2009; 32(8):625-36. PubMed ID: 19591528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterial cell interactions: are current in vitro tests reliable?
    Hirsch C; Roesslein M; Krug HF; Wick P
    Nanomedicine (Lond); 2011 Jul; 6(5):837-47. PubMed ID: 21793675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem Cells, a New Generation Model for Predictive Nano Toxicological Assessment.
    Suma RN; Mohanan PV
    Curr Drug Metab; 2015; 16(10):932-9. PubMed ID: 26467070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-Based Bacterial Viability Assay for Interference-Free and High-Throughput Toxicity Screening of Nanomaterials.
    Qiu TA; Nguyen TH; Hudson-Smith NV; Clement PL; Forester DC; Frew H; Hang MN; Murphy CJ; Hamers RJ; Feng ZV; Haynes CL
    Anal Chem; 2017 Feb; 89(3):2057-2064. PubMed ID: 28208291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.